A Prospective, Multicenter, Randomized, Parallel-Arm, Bilateral, Double-Masked, Vehicle Controlled Feasibility Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Dexamethasone (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 09 Aug 2016 Status changed from active, no longer recruiting to completed, according to Ocular Therapeutix media release.
- 10 Mar 2016 Primary endpoint (Corneal Fluorescein Staining and Conjunctival Lissamine Green Staining using the NEI Scale) has been met, according to an Ocular Therapeutix media release.
- 10 Feb 2016 Planned End Date changed from 1 Dec 2015 to 1 Apr 2016, as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History